Organization · Venture Capital
Privilège Ventures
Privilège Ventures is a Swiss-based early-stage venture capital firm founded in 2021, focusing on seed and early-stage investments in innovative startups across Europe, particularly in HealthTech, CleanTech, and AgriFoodTech.
Overview
What Privilège Ventures does
What Privilège Ventures is
Privilège Ventures is a Swiss-based early-stage venture capital firm founded in 2021, focusing on seed and early-stage investments in innovative startups across Europe, particularly in HealthTech, CleanTech, and AgriFoodTech.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- April 26, 2026
Official channels
Find Privilège Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Privilège Ventures as a funder
Investment thesis
Privilège Ventures backs bold, ambitious founders building breakthrough innovations in HealthTech, CleanTech, and AgriFoodTech, emphasizing scientific and technical expertise, active governance, and long-term value creation.
Focus narrative
Privilège Ventures invests in early-stage companies, particularly in HealthTech, CleanTech, and AgriFoodTech sectors. The firm targets gender-mixed startups from pre-seed to Series A stages, primarily across Europe with a focus on Switzerland. Their investment approach emphasizes long-term value creation and strategic partnerships, ensuring that founders receive the support they need to succeed.
Value beyond capital
Privilège Ventures provides hands-on support, governance, scientific and technical diligence, and access to a community of investors, founders, and experts. The firm emphasizes active engagement with portfolio companies, ensuring they benefit from strategic guidance and resources to scale effectively.
Terms and economics
- Typical check
- $1,500,000–$3,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- HealthcareFood & Agriculture
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
AVELO AG: Focused on developing a novel breath aerosol collection kit for airborne Mycobacterium tuberculosis. ANNAIDA: An EIC Transition beneficiary that recently closed pre-Series A funding. SMEETZ: Engaged in strategic partnerships to enhance its operations in Switzerland. INERGIO: Clean energy/power technology company. XSENSIO: Wearable biosensing/deeptech company involved in Series A financing.
Common questions
What to know about Privilège Ventures
Upseed classifies Privilège Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 26, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.